Concepedia

James L. Palmer

JL

15

Publications

815

Citations

13

H-Index

1987

Active since

Affiliations

Novo Nordisk (Denmark)(Current)

Novo Nordisk (Switzerland)

Health Economics and Outcomes Research (United Kingdom)

Eli Lilly (United States)

Swansea University

James L. Palmer is an author at Novo Nordisk (Denmark) specializing in medicine, diabetes, and health economics.

Top concepts

Publications per year

1987–2015

15

Publications

15

Validation of the IMS CORE Diabetes Model

Phil McEwan, V. Foos, James L. Palmer et al. · Value in Health · 2014 · 229 citations

Energy metabolism and aging: a lifelong study of Fischer 344 rats

Roger McCarter, James L. Palmer · American Journal of Physiology-Endocrinology and Metabolism · 1992 · 199 citations

, , +20

Economic impact of severe and non-severe hypoglycemia in patients with Type 1 and Type 2 diabetes in the United States

V. Foos, N. Varol, Bradley Curtis et al. · Journal of Medical Economics · 2015 · 118 citations · Full text

Cost-utility of exenatide once weekly compared with insulin glargine in patients with type 2 diabetes in the UK

Amélie Beaudet, James L. Palmer, L. Timlin et al. · Journal of Medical Economics · 2011 · 45 citations · Full text

Cost-effectiveness of switching to biphasic insulin aspart in poorly-controlled type 2 diabetes patients in China

James L. Palmer, Meaghan Gibbs, H Scheijbeler et al. · Advances in Therapy · 2008 · 44 citations

, , +9

Rows per page

1–5 of 15